The impact of telehealth applications on pregnancy outcomes and costs in high-risk pregnancy: A systematic review and meta-analysis.

Introduction: Telehealth is an applicable, acceptable, cost-effective, easily accessible, and speedy method for pregnant women. This study aimed to examine the impact of telehealth applications on pregnancy outcomes and costs in high-risk pregnancies.

Methods: Studies were selected from PubMed, Science Direct, Web of Science, EBSCO, Scopus, and Clinical Key databases according to the inclusion and exclusion criteria from January to February 2021. Cochrane risk-of-bias tools were used in the quality assessment of the studies.

Results: Four observational and eight randomized controlled studies were included in this meta-analysis (telehealth: 135,875, control: 94,275). It was seen that the number of ultrasound ( < 0.01) and face-to-face visits ( < 0.01), fasting insulin (< 0.01), hemoglobin A1C before delivery ( < 0.01), and emergency cesarean section rates ( = 0.05) were lower in the telehealth group. In the telehealth group, the women's use of antenatal corticosteroids ( = 0.03) and hypoglycemic medication at delivery ( = 0.03), the total of nursing interventions ( < 0.01), compliance with actual blood glucose measurements ( < 0.01), induction intervention at delivery ( = 0.003), and maternal mortality ( < 0.001) rates were higher. Two groups were similar in terms of the use of medical therapy, total gestational weight gain, health problems related to pregnancy, mode and complications of delivery, maternal intensive care unit admission, fetal-neonatal growth and development, neonatal health problems and mortality, follow-up, and care costs.

Discussion: Telehealth and routine care yielded similar maternal/neonatal health and cost outcomes. It can be said that telehealth is a safe technique to work with in the management of high-risk pregnancies.